Related Experiment Video
Updated: Aug 19, 2026

Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice
Published on: January 7, 2019
[Mianserin: pharmacology and clinical aspects of an effective antidepressive agents]
1Psychiatrische Klinik mit Poliklinik, Universität Erlangen-Nürnberg.
Abstract:
Among the non-tricyclic "newer" antidepressants, mianserin is one of the most thoroughly investigated agents. In the present review its chemical and pharmacological properties, as well as clinically relevant aspects of the use of this antidepressant are discussed. In the first instance, mianserin is indicated for the treatment of depressive illness associated with anxiety and agitation, even including severe forms of depression. Mianserin is characterised by a favourable side effect profile and low toxicity, and thus offers distinct advantages in the treatment of he elderly, as also in patients with a suicidal tendency.
More Related Videos
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...